These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1072574)

  • 1. [Risks of long-term therapy with immunosuppressive agents (proceedings)].
    Thumb N
    Acta Med Austriaca Suppl; 1976; 3():203. PubMed ID: 1072574
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rare opportunistic disease in a patient treated with immunosuppressive therapy for rheumatoid arthritis].
    Baixauli Rubio A; Rodríguez Górriz E; Campos Fernández C; Calvo Catalá J; García Vicente S
    An Med Interna; 2003 May; 20(5):276-7. PubMed ID: 12831311
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive therapy in rheumatoid arthritis.
    Rainer F
    Acta Med Austriaca; 1988; 15(5):137-40. PubMed ID: 3064524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?
    McLean-Tooke A; Aldridge C; Waugh S; Spickett GP; Kay L
    Rheumatology (Oxford); 2009 Aug; 48(8):867-71. PubMed ID: 19447771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of immunosuppressive drugs in the treatment of rheumatoid arthritis].
    Pascual Gómez E
    Med Clin (Barc); 1983 Oct; 81(12):540-4. PubMed ID: 6656371
    [No Abstract]   [Full Text] [Related]  

  • 6. [Symposium II. 4-1. Long-term immunosuppressive therapy for rheumatoid arthritis].
    Kobayashi I; Imura S
    Ryumachi; 1973 Jan; 13(1):48-9. PubMed ID: 4726792
    [No Abstract]   [Full Text] [Related]  

  • 7. [Symposium II. Immunosuppressive therapy in rheumatoid arthritis. 3. Pathologic effects of immunosuppressive agents and their adverse anti-inflammatory effects].
    Kyogoku M; Watanabe S; Sagino H; Obu R; Shimomura R
    Ryumachi; 1973 Jan; 13(1):38-47. PubMed ID: 4726791
    [No Abstract]   [Full Text] [Related]  

  • 8. Kaposi's sarcoma, rheumatoid arthritis and immunosuppressive and/or corticosteroid therapy.
    Casoli P; Tumiati B
    J Rheumatol; 1992 Aug; 19(8):1316-7. PubMed ID: 1290515
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose immunosuppressive therapy for rheumatoid arthritis: some answers, more questions.
    McSweeney PA; Furst DE; West SG
    Arthritis Rheum; 1999 Nov; 42(11):2269-74. PubMed ID: 10555019
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive agents in the therapy of rheumatism].
    Dreyfus P; Dorfmann H
    Munch Med Wochenschr; 1969 Sep; 111(39):1989-91. PubMed ID: 5394419
    [No Abstract]   [Full Text] [Related]  

  • 11. [Present-day problems of immunosuppressive therapy of infectious nonspecific (rheumatoid) arthritis].
    Astapenko MG
    Ter Arkh; 1975; 47(5):122-6. PubMed ID: 1162609
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect and mode of faction of chlorambucil in rheumatoid arthritis. The importance of the lymphoblast transformation test.
    Bontoux D; Kahan A; Brouilhet H; Amor B; Delbarre F; Jouanneau M; Gniazdowska E
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):166-72. PubMed ID: 5552537
    [No Abstract]   [Full Text] [Related]  

  • 13. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"].
    Krüger K
    MMW Fortschr Med; 2002 Aug; 144(33-34):25-30. PubMed ID: 12380140
    [No Abstract]   [Full Text] [Related]  

  • 14. Rheumatoid arthritis.
    Emery P; Foster W; Suarez-Almazor M
    Clin Evid; 2002 Jun; (7):1101-21. PubMed ID: 12230730
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive agents in rheumatoid polyarthritis. Introduction].
    de Sèze S; Kahn MF
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):737-9. PubMed ID: 5152705
    [No Abstract]   [Full Text] [Related]  

  • 16. Tacrolimus therapy in rheumatoid arthritis.
    McCarey DW; Capell HA; Madhok R
    Rheumatology (Oxford); 2004 Aug; 43(8):946-8. PubMed ID: 15187241
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of immunosuppressive agents in the treatment of rheumatoid polyarthritis in adults].
    Le Loet X; Deshayes P
    LARC Med; 1983; 3(6):413-5. PubMed ID: 6888107
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possibilities and limitatious of immunosuppressive therapy].
    Chlud K
    Verh Dtsch Ges Rheumatol; 1976; 4():470-6. PubMed ID: 826034
    [No Abstract]   [Full Text] [Related]  

  • 19. Immuno suppressive drugs in rheumatoid arthritis-toxicity.
    Currey HL
    Adv Clin Pharmacol; 1974; 6():98-104. PubMed ID: 4478796
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunosuppressive agents in the basic therapy of visceral forms of rheumatoid arthritis in children].
    Kölle G; Stoeber E; Schöntag W
    Med Klin; 1972 Apr; 67(17):603-7. PubMed ID: 4624842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.